| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.16 | 0.006 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |